Western blots performed from tumor lysates showed that PLA2G16 overexpression group (WT) is associated higher ERK1/2 phosphorylation (Figure 8D), further supporting that activation of ERK1/2 phosphorylation in tumors is downstream of PLA2G16. The gene discussed is MAPK3; the disease is neoplasm.